RMRA MOVSESIAN

RA MOVSESIAN

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


RA MOVSESIAN has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pediatric cardiovascular surgery in Russia: from fundamental barriers to high-tech solutions

    by Ilya A. Soynov, Ruben R. Movsesyan

    Introduction: Pediatric cardiovascular surgery in Russia is undergoing a major transformation. Along with further reduction in mortality, increasing emphasis is being placed on long-term quality of life, reduction of disability, personalized treatment, and continuity of care for patients with congenital heart disease. Objective: To systematize the key scientific and clinical directions, fundamental barriers, and promising technological solutions in the development of pediatric cardiovascular surgery in Russia. Materials: This study was designed as an analytical (narrative) review. Recent Russian and international publications were analyzed together with materials reflecting scientific and clinical activities of 27 leading Russian centers participating in a multicenter pediatric cardiovascular surgery initiative. Sources were selected thematically, with emphasis on perinatal cardiology, neonatal surgery, bioengineering, neuroprotection, Fontan circulation, arrhythmology, immunological consequences of cardiac surgery, and organizational models of patient routing and follow-up. Results: The major barriers identified include the vulnerability of newborns with critical congenital heart disease and extremely low birth weight, the mismatch between a child’s growth and the durability of current prosthetic materials, neurocognitive sequelae aftercardiopulmonary bypass, long-term complications of Fontan circulation,arrhythmologic problems after congenital heart defect repair, andimmune-related risks associated with thymectomy and geneticallydetermined immune dysfunction. Strategic solutions include predictiveperinatal diagnostics, improved organ protection, development of domestic bioengineering and transcatheter technologies, 3D modeling and digital twins, establishment of dedicated Fontan centers, expansion of mechanical circulatory support and transplantation programs, and implementation of telemedical monitoring and interdisciplinary rehabilitation. Conclusion: The development of pediatric cardiovascular surgery in Russia requires integration of clinical, bioengineering, digital, and organizational solutions. The combination of domestic innovations,multicenter collaboration, and national registries may improve treatment effectiveness, long-term outcomes, and technological independence of the field. Received 13 May 2026. Revised 18 June 2026. Accepted 19 June 2026. FundingThe study did not have sponsorship. Conflict of interestThe authors declare no conflict of interest. AcknowledgmentsThe authors sincerely thank the teams and leadership of the following medical institutions for their support and for providing data on research directions: Bakulev National Medical Research Center for Cardiovascular Surgery (Moscow); Almazov National Medical Research Center (St. Petersburg); Meshalkin National Medical ResearchCenter (Novosibirsk); Cardiology Research Institute, Tomsk National Research Medical Center; Research Institute for Complex Issues of Cardiovascular Diseases (Kemerovo); Shumakov National Medical Research Center of Transplantology and Artificial Organs (Moscow); St. Petersburg State Pediatric Medical University; Federal Centers for High Medical Technologies and Cardiovascular Surgery (Kaliningrad, Chelyabinsk, Perm, Penza, Astrakhan, Krasnoyarsk, Khabarovsk); Republican Cardiology Center (Ufa); Children’s Republican Clinical Hospital (Kazan);Children’s City Multidisciplinary Clinical Specialized Center for High Medical Technologies (Children’s Hospital No. 1, St. Petersburg); Morozov Children’s City Clinical Hospital and N.F. Filatov Children’s City Clinical Hospital (Moscow); Regional Clinical Hospital No. 1 (Tyumen); S.V. Ochapovsky Research Institute – Regional Clinical Hospital No. 1 (Krasnodar); Korolev Specialized Clinical Hospital (Nizhny Novgorod); Volgograd Regional Clinical Cardiology Center; Polyakov Specialized Clinical Cardiology Dispensary (Samara); Rostov Regional Clinical Hospital; Regional Clinical Hospital No. 1 (Yekaterinburg); and the Center for Diagnostics and Cardiovascular Surgery, Regional ClinicalCardiology Dispensary (Surgut). Contribution of the authors Conception and study design: R.R. Movsesyan Data collection and analysis: I.A. Soynov Drafting the article: both authors Critical revision of the article: I.A. Soynov Final approval of the version to be published: both authors

  • Thirty-year experience of arterial switch surgery in a single hospital

    by R.R. Movsesyan, N.V. Antsygin, A.A. Shikhranov, G.M. Chizhikov, A.L. Tsytko, D.E. Zuev, M.V. Boriskov, A.A. Morozov, V.G. Lyubomudrov

    ЦЕЛЬ ИССЛЕДОВАНИЯ Представить результаты анатомической коррекции транспозиции магистральных артерий (ТМА) за период с 1992 по 2021 г. МАТЕРИАЛ И МЕТОДЫ Исследование включало 504 ребенка с ТМА, из них у 120 (23,8%) больных порок был ассоциирован с дефектом межжелудочковой перегородки (ДМЖП), у 60 (11,9%) пациентов сочетался с ДМЖП и обструкцией дуги аорты. Всем детям была выполнена одномоментная коррекция ТМА методом артериального переключения, а также коррекция сопутствующих внутрисердечных аномалий. РЕЗУЛЬТАТЫ Общая госпитальная летальность за все годы составила 7,9% (40 пациентов) со значительным снижением от 15,8% в 1992—2001 гг. до 2,1% в 2017—2021 гг. Отдаленные результаты прослежены у 464 детей в срок до 18 лет. Летальность в указанный период отсутствовала. Свобода от реинтервенций в группах «ТМА-интактная МЖП», «ТМА-ДМЖП» и «ТМА-ДМЖП-обструкция аорты» составила 88, 81,3 и 53,1% соответственно. В большинстве случаев повторные вмешательства выполняли на легочной артерии (13 (13,3%) детей) и дуге аорты после устранения ее обструкции (9 (18,3%) детей). ВЫВОД Первичная радикальная коррекция ТМА с использованием методики артериального переключения демонстрирует низкие показатели летальности и хорошие отдаленные результаты. Наличие ассоциированных пороков сердца обуславливает потенциально большую потребность в повторных вмешательствах у данной категории больных в отдаленном периоде. Наиболее частые повторные вмешательства связаны с развитием стеноза легочной артерии, а также рекоарктации аорты после ранее выполненной реконструкции дуги аорты.


  • The treatment of choice for urgent intervention in children with severe/critical TAPVC

    by A.A. Morozov, R.R. Movsesyan, St. Petersburg Children’s City Hospital # 1, M.V. Boriskov, V.A. Belov, Kaliningrad Federal Center For High Medical Technologies, P.V. Teplov, Krasnoyarsk Federal Center For Cardiovascular Surgery, A.K. Latypov, E.V. Grekhov, et al.

    Выбор тактики оказания экстренной хирургической помощи детям с тотальным аномальным дренажем легочных вен

  • Surgical treatment of isolated total anomalous pulmonary venous connection in newborns: risk factors and results

    by A.A. Morozov, R.R. Movsesyan, T.M. Pervunina, E.V. Grekhov, N.V. Fedorova, A.K. Latypov, E.S. Vasichkina, St. Petersburg Children’s City Hospital # 1

  • Evolution of total anomalous pulmonary venous connection surgery

    by A.A. Morozov, R.R. Movsesyan, St. Petersburg Children’s City Hospital # 1, M.V. Boriskov, V.A. Belov, Kaliningrad Federal Center For High Medical Technologies, P.V. Teplov, Krasnoyarsk Federal Center For Cardiovascular Surgery, E.V. Grekhov, A.K. Latypov

    Эволюция техник хирургического лечения тотального аномального дренажа легочных вен

    • 1 January 2013
      • Vol. 172  (6) , 12-5

    [Results of surgical treatment of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries].

    by R R Movsesian, G M Chizhikov, A A Morozov, A A Shikhranov, N V Antsygin, V A Bolsunovskiĭ, V G Lubomudrov

    This article presents the 14-year experience of surgical treatment of pulmonary atresia with ventricular septal defect and pulmonary collateral blood bed. The surgery of defect was performed on 32 patients and they were followed up. The individual and differential approaches should be used in the choice of surgical strategy. This approach is based on the state of pulmonary arterial and collateral beds. An integral criterion of assessment was the common neo-pulmonary arterial index with boundary measure equal 150 mm2/m2. An application of given method allowed the performance of successful radical repair of defect in 15 patients, 4 patients having been operated in one stage. The rest of the patients had the appropriate staged interventions. The lethality consisted of 9.4%.

  • Open Access

    eComment: Re: Do we need fenestration when performing two-staged total cavopulmonary connection using an extracardiac conduit?

    by Leo A. Bockeria, Ruben R. Movsesian

    The results of the Fontan operation depend on initial hemodynamic. In our opinion fenestration in Fontan circuit should not be a routine procedure. Some pharmacological agents reduce pulmonary vascular resistance thus decreasing venous pressure [1]. We agree with the necessity of fenestration after cardiopulmonary bypass in high-risk patients [2]. We believe that Fontan operation with complex concomitant intracardiac procedures and venous pressure higher than 18 mmHg in the postoperative period are indications for fenestration. Given results are based on a perfect surgical and pharmacological strategy and optimal indications to Fontan operation.

    • 1 January 2009
      • No. 12,p. 36-8

    [Results of bidirectional cavapulmonary shunt operation without cardiopulmonary bypass in children with complicated congenital heart defects during the first year of life].

    by L A Bokeriia, A I Kim, R R Movsesian, I I Boltabaev, T V Rogova, A G Zakharchenko, O V Erokhina

    The authors present results of bidirectional cavapulmonary shunt operation without cardiopulmonary bypass for the treatment of complicated congenital heart defects. Temporary blood shunting during surgical intervention enables cavapulmonary anastomosis to be created without making resort to artificial circulation (AC) and limitation on the time of superior vena cava occlusion. The proposed method is free from additional risks and excludes negative effects of AC. It allows for conversion to AC as appropriate at any time during surgery in the "bypass stand-by" regime.